SOFIA (Bulgaria), April 30 (SeeNews) -Â Bulgarian drug maker Sopharma [BUL:3JR] said that its non-consolidated net profit rose to 12.9 million levs ($7.4 million/6.6 million euro) in the first quarter of 2019 from 12.4 million levs in the same period of last year.